Today: 14 June 2026
Browse Category

NASDAQ:HTH 30 January 2026

Hilltop Holdings (HTH) stock climbs after dividend hike, new $125 mln buyback and Q4 profit lift

Hilltop Holdings (HTH) stock climbs after dividend hike, new $125 mln buyback and Q4 profit lift

Hilltop Holdings shares rose 2.9% to $37.87 Friday after the company reported a Q4 profit of $41.6 million and raised its quarterly dividend to $0.20 per share. The board approved a new $125 million stock buyback plan through January 2027. Mortgage originations reached $2.4 billion for the quarter. The bank set aside $7.8 million for credit losses as non-accrual loans declined.

Stock Market Today

  • Trulieve First Major US Cannabis Operator to List on NYSE
    June 14, 2026, 12:22 AM EDT. Trulieve Cannabis Corp. made history on June 10 by becoming the first US-based, plant-touching cannabis company to list on the New York Stock Exchange under the ticker TRLV. The shares opened between $10 and $12, valuing the company at about $2 billion. This breakthrough follows the reclassification of medical marijuana from Schedule I to Schedule III by the DEA, enabling compliant companies to access major US exchanges. Trulieve separated its adult-use recreational cannabis into Harvest Enterprises, allowing its medical cannabis operations to list on the NYSE and attract institutional investors previously barred due to regulatory constraints. This move unlocks access to pension funds and ETFs that only purchase securities on major exchanges, though investors now face a business focused solely on medical cannabis, which differs in growth and margins from the recreational market. Harvest Enterprises may pursue its own public offering in the future.

Latest articles

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

Kraft Heinz Shares Rally for Six Days—Is KHC a Buy Now?

14 June 2026
Kraft Heinz closed up 0.70% at $24.39, outpacing the S&P 500, as investors weighed its 6.6% dividend yield against falling organic sales, lower adjusted earnings, and cautious analyst targets; the next earnings update is seen as the key test for whether $600 million in marketing and R&D can revive growth and support the stock’s rebound.
Go toTop